Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.


TSX:CPH - Post by User

Comment by Maxmoeon Jan 04, 2021 12:24pm
116 Views
Post# 32215695

RE:RE:Takeover talks with Bausch Health?

RE:RE:Takeover talks with Bausch Health?

So I dug a little and apparently there are more companies in Canada that could us those tax losses than I assumed other than Bausch so they better grab it while they can. There's a few privates that book actual profit and pay real taxes that could qualify, so you never know.

Maxmoe wrote: Sounds like logical analysis to me but where does the $3 number come from.  Is it from Mars, some other planet, or is there a similarly logical pathway? I've rarely seen tax losses sell for anything much more than an icing on the cake freebie. Like 5% maybe. I guess if our pals in Ottawa jack up tax rates they may be worth a little more.

r0nald wrote:

Arbitration award soon to be expected and Cipher still discussing an agreement with Bausch.
Could these talks be about a takeover I wonder?

As we know Cipher has told us (in september?) they were in the final stages of closing a distribution deal.
Nothing since.
Then in the Q3 call we were told they are working on a tax loss deal.
Nothing since.

Pretty sure any distribution deal or tax loss deal Cipher closes would be a pain in the #ss of Bausch if they have any takeover plans.
Bausch could distribute anything Cipher has in their portfolio and could probably find ways using Ciphers tax loss.

Bausch probably would have to pay big time when the arbitrator rules. And they know it.
Better buy Cipher for a known amount and get their business and tax loss too.

I'm really starting to think that talks with Bausch are the cause of (promised) Cipher deals not being closed yet.

So, lets talk numbers. $3? ;)
 





<< Previous
Bullboard Posts
Next >>